Passive Roboter zur Schlaganfallrehabilitation: Eine Machbarkeitsstudie
Passive Roboter zur Schlaganfallrehabilitation
The purpose of this study is to examine the feasibility and effectiveness of a novel, multimodal approach that combines passive devices with noninvasive neuromuscular stimulation for upper extremity rehabilitation after stroke.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
About 800,000 individuals suffer from a stroke every year in the United States. The majority of stroke survivors often experience lingering deficits in upper extremity function. High-end robotic devices can improve outcomes and clinical productivity; however, these devices are expensive and bulky, making them not practical for many clinical or home environments. This study aims to evaluate the feasibility of low-cost non-motorized devices for stroke rehabilitation in a long-term intervention. The intervention will involve training with a table-top, semi-passive (i.e., no motors) exercise equipment called SepaRRo and commonly-used neuromuscular stimulation. The stimulation will be provided during functional activities using a custom controller (NeuRRoFES) to trigger stimulation. These instruments are designed to provide flexible, compliant assistance/resistance to improve upper extremity function and can be used in a home setting. The study will measure technical feasibility (e.g., qualitative survey, adherence, time on task, retention, ability to perform tasks) as well as clinical feasibility (i.e., changes in biomechanical, neurophysiological, and functional measures) of an intervention with these devices in stroke survivors. The findings aim to support the development of affordable, home-use rehabilitation systems for stroke patients.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Chandramouli Krishnan, PT, PhD
- Telefonnummer: 7349364031
- E-Mail: mouli@umich.edu
Studieren Sie die Kontaktsicherung
- Name: Thomas E Augenstein, PhD
- Telefonnummer: 7342320898
- E-Mail: tomaugen@umich.edu
Studienorte
-
-
Michigan
-
Ann Arbor, Michigan, Vereinigte Staaten, 48108
- Rekrutierung
- University of Michigan - NeuRRo Lab
-
Hauptermittler:
- Chandramouli Krishnan, PT PhD
-
Kontakt:
- Thomas E. Augenstein, PhD
- Telefonnummer: (734) 936-4031
- E-Mail: tomaugen@umich.edu
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Age 18 to 75 years;
- Ischemic or hemorrhagic stroke confirmed by CT, MRI, or clinical criteria;
- No major deficits of sensation or proprioception;
Exclusion Criteria:
- Bilateral stroke
- Unable to think clearly and remember (Mini-Mental State Exam score < 22 and miniMOCA < 8);
- Uncontrolled Diabetes or Hypertension;
- Severe limitations of joint range of motion that will lead to inability of testing
- Severe spasticity and joint contractures that will lead to inability of testing
- Complete paresis with no possible movements
- Severe aphasia
- Any other medical condition that will significantly impact the study results
- Unable to obtain reliable motor evoked potentials
- Are pregnant or are actively trying to conceive
- Have a recent history of repeated fainting spells or syncope.
- Have a recent history of seizure (epilepsy) while on anti-seizure medication
- Have a recent history of skull fracture/head injury
- Have metal implants in the skull
- Have cardiac pacemakers
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Machbarkeit des Geräts
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Robotic Intervention
Participants will receive upper extremity rehabilitation using SepaRRo and NeuRRoFES 2-5 times per week for 2-6 weeks |
Participants will perform functional movements (e.g., reach for targets) with their extremities. During movements, the devices will be used to assist or resist their motion. Participants may receive biofeedback of their movements to better engage them in training. Participants may receive assistance from the devices (including neuromuscular stimulation) and/or their less-impaired limb. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Device Survey For Feasibility
Zeitfenster: Post-intervention (immediately following last session of intervention)
|
Subjective feedback regarding feasibility of the device for training |
Post-intervention (immediately following last session of intervention)
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Retention
Zeitfenster: Post-intervention (immediately following last session of intervention)
|
Measure of how many participants completed intervention |
Post-intervention (immediately following last session of intervention)
|
|
Adherence
Zeitfenster: Post-intervention (immediately following last session of intervention)
|
Measure of percentage of sessions completed |
Post-intervention (immediately following last session of intervention)
|
|
Upper extremity Fugl-Meyer Score
Zeitfenster: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively.
|
Changes in upper extremity Fugl-Meyer score from before the intervention (from baseline) to after its completion using publicly available scoring sheets. The Fugl-Meyer score is a measure of functional impairment and runs from 0 to 66 points, with higher numbers reflecting better outcome. |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively.
|
|
Reachable workspace
Zeitfenster: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in reachable workspace from before the intervention (from baseline) to after its completion). The reachable workspace area will be measured with SepaRRo obtained from optical encoders mounted in the device. |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
|
Voluntary hand opening
Zeitfenster: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in voluntary ability to open the hand from before the intervention (from baseline to after its completion). Voluntary hand opening will be measured with motion capture equipment. |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
|
Action Research Arm Test Score
Zeitfenster: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in the Action Research Arm Test Score from before the intervention (from baseline) to after its completion using publicly available scoring sheets. The Action Research Arm Test is a measure of arm functional ability and runs from 0 to 57 points, with higher numbers reflecting better outcome. |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
|
Box and Block (BBT)
Zeitfenster: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in functional measure of arm disability (BBT) from before the intervention (from baseline) to after its completion using publicly available scoring sheets. |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
|
Hand Strength
Zeitfenster: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in force produced by the hand from before the intervention (from baseline) to after its completion as measured by force production recorded with a dynamometer |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
|
Arm strength
Zeitfenster: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in force produced by the arm from before the intervention (from baseline) to after its completion as measured by force production recorded with a dynamometer |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
|
Muscle coordination
Zeitfenster: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in muscle coordination of the upper extremity muscles as measured using surface electromyography between before the intervention (from baseline) to after its completion. |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
|
Joint coordination
Zeitfenster: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in coordination of the upper extremity joints as measured motion capture between before the intervention (from baseline) to after its completion. |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
|
Corticospinal excitability
Zeitfenster: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in corticospinal excitability of the upper extremity muscles as measured using surface electromyography and transcranial magnetic stimulation between before the intervention (from baseline) to after its completion |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Chandramouli Krishnan, PT, PhD, University of Michigan
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- HUM00087962
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .